Albert E Barskey1, Deven Lackraj2, Priti Shah Tripathi3, Sooji Lee2, Jessica Smith4, Chris Edens4. 1. Division of Bacterial Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA. Electronic address: abarskey@cdc.gov. 2. IHRC, Inc., Atlanta, GA, USA. 3. Oak Ridge Institute for Science and Education (ORISE), Oak Ridge, TN, USA. 4. Division of Bacterial Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA.
Abstract
BACKGROUND: Recent travel is associated with ~20% of reported Legionnaires' disease (LD) cases worldwide. METHODS: We analyzed LD cases reported to the Centers for Disease Control and Prevention (CDC) during 2015-2016. Travel-associated cases met case criteria for confirmed LD in someone who spent ≥1 night away from home during the 10 days before symptom onset. Most analyses were limited to travel-associated, public accommodation stay (TAPAS) cases. We used reported travel dates to estimate the number of TAPAS cases acquired during travel. RESULTS: Of 12,200 LD cases reported among U.S. residents, 12.3% were travel-associated; 8.7% were TAPAS. Median patient age for TAPAS cases was 61 years; 64.4% were male; 67.3% were white; 77.9% were non-Hispanic; 96.1% were hospitalized; 4.5% died. Among 887 TAPAS cases involving U.S. destinations, an estimated 29.8% were acquired during travel; 4.28 TAPAS cases were reported, and an estimated 1.10 TAPAS cases were acquired during travel, per 10,000,000 hotel room nights booked. Sixty-eight U.S. TAPAS clusters were detected. CONCLUSIONS: While acquisition during travel accounted for a relatively small proportion of all LD cases, clusters of TAPAS cases were frequently detected. Prompt notification of these cases to CDC facilitates cluster detection and expedites intervention. Published by Elsevier Ltd.
BACKGROUND: Recent travel is associated with ~20% of reported Legionnaires' disease (LD) cases worldwide. METHODS: We analyzed LD cases reported to the Centers for Disease Control and Prevention (CDC) during 2015-2016. Travel-associated cases met case criteria for confirmed LD in someone who spent ≥1 night away from home during the 10 days before symptom onset. Most analyses were limited to travel-associated, public accommodation stay (TAPAS) cases. We used reported travel dates to estimate the number of TAPAS cases acquired during travel. RESULTS: Of 12,200 LD cases reported among U.S. residents, 12.3% were travel-associated; 8.7% were TAPAS. Median patient age for TAPAS cases was 61 years; 64.4% were male; 67.3% were white; 77.9% were non-Hispanic; 96.1% were hospitalized; 4.5% died. Among 887 TAPAS cases involving U.S. destinations, an estimated 29.8% were acquired during travel; 4.28 TAPAS cases were reported, and an estimated 1.10 TAPAS cases were acquired during travel, per 10,000,000 hotel room nights booked. Sixty-eight U.S. TAPAS clusters were detected. CONCLUSIONS: While acquisition during travel accounted for a relatively small proportion of all LD cases, clusters of TAPAS cases were frequently detected. Prompt notification of these cases to CDC facilitates cluster detection and expedites intervention. Published by Elsevier Ltd.
Authors: K Lock; C Millett; R Heathcock; C A Joseph; T G Harrison; J V Lee; G Rao; S Surman-Lee Journal: Epidemiol Infect Date: 2007-12-19 Impact factor: 2.451
Authors: D Che; C Campese; P Santa-Olalla; G Jacquier; D Bitar; P Bernillon; J-C Desenclos Journal: Epidemiol Infect Date: 2008-01-23 Impact factor: 2.451
Authors: Jane E Greig; John A Carnie; Graham F Tallis; Norbert J Ryan; Agnes G Tan; Ian R Gordon; Bernard Zwolak; Jennie A Leydon; Charles S Guest; William G Hart Journal: Med J Aust Date: 2004-06-07 Impact factor: 7.738
Authors: Laurel E Garrison; Jasen M Kunz; Laura A Cooley; Matthew R Moore; Claressa Lucas; Stephanie Schrag; John Sarisky; Cynthia G Whitney Journal: MMWR Morb Mortal Wkly Rep Date: 2016-06-10 Impact factor: 17.586
Authors: Leonor Sánchez-Busó; Silvia Guiral; Sebastián Crespi; Víctor Moya; María L Camaró; María P Olmos; Francisco Adrián; Vicente Morera; Francisco González-Morán; Hermelinda Vanaclocha; Fernando González-Candelas Journal: Front Microbiol Date: 2016-01-21 Impact factor: 5.640